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Abstract
Background: In South Asia, where most stillbirths and neonatal deaths occur, much remains unknown about the
causes of these deaths. About one-third of neonatal deaths are attributed to prematurity, yet the specific conditions
which cause these deaths are often unclear as is the etiology of stillbirths. In low-resource settings, most women
are not routinely tested for infections and autopsy is rare.
Methods: This prospective, cohort study will be conducted in hospitals in Davengere, India and Karachi, Pakistan.
All women who deliver either a stillbirth or a preterm birth at one of the hospitals will be eligible for enrollment.
With consent, the participant and, when applicable, her offspring, will be followed to 28-days post-delivery. A series
of research tests will be conducted to determine infection and presence of other conditions which may contribute
to the death. In addition, all routine clinical investigations will be documented. For both stillbirths and preterm
neonates who die ≤ 28 days, with consent, a standard autopsy as well as minimally invasive tissue sampling will be
conducted. Finally, an expert panel will review all available data for stillbirths and neonatal deaths to determine the
primary and contributing causes of death using pre-specified guidance.
Conclusion: This will be among the first studies to prospectively obtain detailed information on causes of stillbirth
and preterm neonatal death in low-resource settings in Asia. Determining the primary causes of death will be important
to inform strategies most likely to reduce the high mortality rates in South Asia.
Trial registration: Clinicaltrials.gov (NCT03438110) Clinical Trial Registry of India (CTRI/2018/03/012281).
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Background
Neonatal mortality is common in South Asia and sub-
Saharan Africa with rates as high as 40 to 50 per 1000
live births in some countries compared to rates as low as
2 per 1000 live births in Scandinavia [1, 2]. Worldwide,
at least 2.6 million neonatal deaths occur annually, with
more than one-third attributed directly to preterm birth
[3]. Globally, the risk of death from preterm birth is
highest in South Asia and sub-Saharan Africa [4]. Al-
though mortality rates are often higher in Africa, numer-
ically, more infants die in South Asia. Preterm neonates
die from prematurity-related complications including re-
spiratory distress syndrome (RDS), necrotizing entero-
colitis (NEC), and intraventricular hemorrhage (IVH), as
well as asphyxia, infection, and congenital anomalies, con-
ditions not always attributed to preterm birth [4]. However,
few cause of death studies—especially in low-resource set-
tings in low and middle-income countries (LMIC)—have
determined specific causes of preterm death, instead attrib-
uting all neonatal deaths of infants < 37 weeks to prema-
turity. Furthermore, little is known about causes of death
among stillbirths in LMIC and especially specific types of
infections associated with stillbirth.
One of the important goals of international organiza-
tions is to reduce neonatal mortality in LMIC, with re-
cent efforts highlighting the importance of improving
survival of preterm infants [5, 6]. Gaps in our knowledge
of the medical conditions that increase risk of death in
preterm infants and the circumstances of these deaths
have impeded progress to improve survival. Determining
major infectious and pathological causes, as well as clin-
ical events that contributed to the death is necessary not
only to understand the cause of death in preterm in-
fants, but also to identify effective treatments to improve
survival.
Less is known about causes of stillbirth than neonatal
mortality. Globally, the highest reported rates of still-
birth occur in Pakistan. In most countries, stillbirth rates
are equivalent to or greater than neonatal mortality rates
with about 3 million third trimester stillbirths occurring
annually. In high-income countries, 50% of stillbirths
occur prior to 28 weeks and fully 80% occur prior to
term [7]. The percent of stillbirths occurring in the pre-
term period in LMIC is unknown. Thus, we estimate
that most perinatal mortality in LMIC occurs in infants
born preterm.
Stillbirths are caused by a variety of maternal and fetal
conditions, including placental abruption, obstructed
labor, preeclampsia, placental insufficiency, infection,
congenital anomalies and cord complications, conditions
that also contribute to neonatal mortality. The distribu-
tion of these causes and the sequence of events leading
to stillbirth in LMIC are generally unknown. One study
suggests that when assessing preterm birth, the true
picture of preterm birth may be obscured if stillbirth is
excluded [8]. Thus, given the substantial overlap in eti-
ologies between preterm neonatal deaths and preterm
stillbirths, and the large contribution of stillbirths to the
preterm birth rate, evaluating causes of death among
stillbirths will substantially increase our understanding
of all preterm deaths.
For both neonatal deaths and stillbirths, infections are
often not identified and have largely been under-
reported in low-resource settings where both logistics
and lack of appropriate technology may limit investiga-
tions into infections. Over 100 organisms have been re-
ported to potentially cause stillbirth or neonatal death
[9]. Since the identification of pathogens responsible for
fetal or neonatal death may not be obtained from blood
cultures alone, the identification process becomes more
complicated with testing required of specific tissues such
as the placenta, and fetal or neonatal organs, often with
molecular assays.
In many regions in South Asia, most deliveries now
occur in health facilities [10]. Despite the dramatic in-
crease in hospital deliveries in the last decade in this re-
gion, little reduction in neonatal mortality or stillbirth
has been realized. Determining the main causes and risk
factors for perinatal mortality will ultimately inform po-
tential strategies to reduce the high neonatal mortality
and stillbirth rates currently seen in South Asia.
Methods and design
Our primary objectives are to determine the primary
causes of death among preterm live-born infants and
stillbirths in South Asia (Pakistan and India) including
determining the main causes of death for preterm in-
fants and stillbirths who are delivered in selected hospi-
tals in India and Pakistan. Secondary objectives include
determining the proportion of stillbirths and neonatal
deaths caused by infection. For stillbirth and preterm
deaths caused by infections, we will also determine the
proportion of deaths caused by specific pathogens of
interest. We also aim to identify maternal and obstetric
risk factors which contribute to preterm deliveries that
result in stillbirth and neonatal death. Finally, we will de-
termine practices in the obstetric unit and neonatal in-
tensive care unit (NICU) associated with risk of stillbirth
or neonatal death and evaluate potential preventability
of these preterm infant deaths and stillbirths.
Design
This prospective, observational cohort study of pregnant
women will evaluate causes of stillbirth and neonatal
death (≤ 28 days) among preterm births. Women who
deliver either a preterm live birth, 20–37 weeks calcu-
lated based on a predefined algorithm, [11, 12] or still-
birth ≥ 20 weeks at any gestational age in a study
McClure et al. Reproductive Health 2018, 15(Suppl 1):89 Page 46 of 126
hospital will be enrolled. Among infants admitted to the
hospital, the clinical care, evaluation and results of any
investigations will be documented with additional, pro-
spectively defined research investigations. Specifically,
the placenta for all deliveries will be collected for evalu-
ation and minimally invasive tissue sampling (MITS) as
well as standard autopsy will be conducted on both still-
births and neonatal deaths with additional consent. Tis-
sues obtained will be evaluated histologically and tested
by PCR for organisms of interest. Among infants not ad-
mitted who ultimately die at home, verbal autopsy per-
formed by a trained health worker will be collected. All
information will be collated to help inform the deter-
mination of cause of death. The final primary cause of
death and contributing fetal/neonatal and maternal fac-
tors will be determined by a panel of experts using all
available information and pre-defined guidance.
Study population
The study will be conducted at 5 to 6 hospitals in Karachi,
Pakistan and in Davangere, India. All women who deliver
at a study hospital in one of these sites will be screened
for study eligibility.
India
Study recruitment will be conducted in Davangere,
India, located in central Karnataka in southern India. In
Davangere, the 3 hospitals include both public and pri-
vate services which together cover the catchment region
surrounding Davangere and reflect the population of the
Karnataka State of India. Altogether, these hospitals have
approximately 16,000 annual deliveries, with an esti-
mated preterm delivery rate of approximately 30%.
Across the three hospitals, the stillbirth rate is about 25
per 1000 deliveries.
Pakistan
Study recruitment will be conducted in Karachi, Pakistan,
located in southern Pakistan. Pregnant women will be re-
cruited in the obstetrics department in the Jinnah Post-
graduate Medical Centre (JPMC) and infants followed at
the neonatal intensive care unit (NICU) at the adjacent
National Institute of Child Health (NICH), which accepts
referrals from JPMC. These hospitals serve a wide range
of the population to provide advanced care of neonates in
Karachi. JPMC has 15,000 annual deliveries with approxi-
mately 35% preterm births. In addition, the stillbirth rate
is estimated at 35 per 1000 deliveries. Other hospitals may
be included as necessary.
Study procedures
Initial screening
Potential study participants will be recruited from study
hospitals in labor and delivery. Upon identification, a
brief assessment of the woman’s eligibility will be made,
which will include her estimated gestational age and the
status of the fetus.
Inclusion and exclusion criteria
Inclusion criteria
■ Pregnant women ≥ 14 years of age.
■ Women who are admitted with an imminent preterm
delivery based on clinical indications
(20–37 weeks gestation) or women who have a known
stillbirth (intrauterine fetal death ≥ 20 weeks).
Exclusion criteria
■ Induced (medical) abortion (< 20 weeks)
■ For live births, Unable to determine the gestational
age at delivery
Ethics and consent
Before a woman participates in any research activity, re-
search staff will obtain her informed consent to volun-
tarily participate in the study. Research staff will give
adequate opportunity to each potential participant and/
or immediate family members to read the consent form
and ask questions. Recognizing the range of literacy
levels in study catchment regions, the consent process
will include a verbal review and explanation of the study
procedures and consent form. If a woman has inad-
equate time to review the study and consent prior to de-
livery, consent may be requested following her delivery.
Families for which a stillbirth or neonatal death occurs
will have additional consent requested for additional in-
vestigations; a team from the hospital will provide the
family with information about the results of relevant
tests and circumstances around their infant’s death or
stillbirth.
The study will be overseen by ethics review commit-
tees at the Aga Khan University (Karachi, Pakistan), KLE
Academy of Higher Education and Research (Belagavi,
India), J.J.M. Medical College (Davangere, India), and
RTI International. Only women with informed consent
will be enrolled in the study.
Gestational age dating
To be included in the study, a woman either delivers a
stillbirth (≥ 20 weeks gestation) or a preterm (< 37 weeks)
live birth. Gestational dating will be done using the hier-
archy of methods established by the American College
of Obstetrics and Gynecology [11, 12], using report of
reliable last menstrual period and ultrasound examina-
tions. If neither is available, the Ballard examination (for
preterm live births) will be used.
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Minimally invasive tissue sampling (MITS)
MITS, a relatively new technique which uses needle bi-
opsies of selected organs to obtain tissue samples for
histology and PCR for organism identification has been
proposed as an alternate method to full autopsy for pro-
viding information on cause of death [13]. In this study,
consent for MITS will be obtained for both stillbirths
and neonatal deaths, in addition to full autopsy, or in
cases wherein the family declines autopsy.
Enrollment procedures
Overview
Following confirmation of eligibility and attainment of
signed informed consent, clinical and research investiga-
tions will be collected as summarized in Table 1. Mater-
nal assessments a rectovaginal swab will be obtained
from each pregnant woman for assessment of group B
streptococcus (GBS). In addition, each participant’s clin-
ical status will be assessed, including a physical examin-
ation, medical and obstetric history, and review of
procedures for current delivery. Immediately following
delivery, the placenta and cord blood will be collected.
Stillbirth assessment
Stillbirths will have a complete assessment including a
physical examination following delivery, photograph and
x-rays (as appropriate). With consent, MITS as well as
an autopsy will be performed. In addition, the placenta
will be examimed grossly and histologically and placental
specimens as well as cord blood samples collected.
Newborn assessment
Newborns will have a physical assessment completed as
soon as possible following delivery, including confirmation
of gestational age. If the clinical examination suggests that
the prior estimation of gestational age is unreliable, the
clinician may exclude term infants following delivery. All
preterm infants enrolled in the study will be followed
through 28 days of life to assess outcomes, regardless of
their admission to the NICU. Among those infants admit-
ted to participating study NICUs, their clinical care, clin-
ical investigations, and any conditions diagnosed during
the NICU admission will be documented. Among those
infants discharged alive prior to or on day 28, a follow-up
visit will be made to assess the infants’ status at 28 days.
For all live-born preterm infants, the placenta will be eval-
uated grossly. A placental specimen will be collected for
potential PCR analysis and the placenta placed in formalin
for potential histological analysis in case of death. In
addition, cord blood will be collected for all births for po-
tential PCR and antibody analyses as well as other assays.
Neonatal death assessment
For those who die within 28 days, a complete assessment
of circumstances surrounding their death including the
clinical summary, an autopsy and/or MITS (with con-
sent) will be performed. For infants who die, their pla-
centa and internal organs will be evaluated histologically
and then PCR for various organisms will be performed.
Cord blood samples will undergo PCR testing for vari-
ous organisms. Because of cost, these tests will only be
performed in cases of neonatal death.
Infectious causes of stillbirth and neonatal death among
preterm infants
Infections are potentially a major and largely under-
reported contribution to stillbirth and neonatal deaths
among preterm births [14, 15]. Since the identification
Table 1 Types of information collected for preterm infants enrolled, neonatal deaths and stillbirths and for NICU admissions
All Enrolled Infants Infant Deaths ≤ 28 days
and Stillbirths
Infants admitted to NICU
General • GA dating by LMP and
US or Ballard examination
• Obstetric history
• Delivery information
• Autopsy
• MITS: brain, liver, blood and
lung tissue samples
• X-ray
• Placental pathology
• Cord blood
• Storage of samples for quality
control
• External physical examination
• Photograph
• Complete blood count
• CRP
• Random blood sugar
• Temperature
• Head ultrasound when clinically
indicated
• Chest and abdominal x-ray when
clinically indicated
• Culture of blood, CSF and others
when clinically indicated
Infection study • Maternal GBS swab
on hospital admission
• Maternal syphilis
screening test
• Maternal serum for
antibody analysis
• Placental tissue (PCR)
• Liver, lung and brain tissue (PCR)
• Cord and/or heart blood (PCR)
For all deaths, we will collect several
fetal/infant dried blood spot cards
(DBS) to be used for organism
confirmation if necessary
Hemoglobin, metabolic
and genetic disorders
Testing for cause of death using
DBS, blood and tissue DNA, if
indicated based on screening criteria
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of pathogens responsible for fetal or neonatal death may
not be possible from fetal blood, it is important to assess
tissues such as the placenta, and fetal or neonatal organs.
Routine tests (related to infection) for the study will
include the following for all preterm infants as clinically
indicated at each of the study hospitals:
 Complete blood count (CBC)
 C-reactive protein (CRP)
 Placental histology (collected at delivery but
analyzed for deaths only)
Clinical investigations to be obtained by the clinical
staff when an infection is suspected include:
 Blood cultures for suspected sepsis
 CSF analysis and culture for suspected meningitis
 Chest x-ray for suspected pneumonia
 Urine culture for suspected urinary tract infection
General approach for infections
In addition to the routine tests for deceased infants,
MITS will be performed for most cases. Through MITS
methodology we will obtain tissues from the, lung, liver,
brain and potentially other organs. In addition, we will
collect placental samples and fetal or neonatal and ma-
ternal blood for research investigation of infection.
We will test all available samples from all stillbirth and
neonatal death cases using a real-time PCR format for
selected organisms. The final selection of pathogens and
methodology will be reviewed with other cause of death
studies to help ensure that the results can be interpreted
across currently funded initiatives to determine cause of
death in LMIC [16]; however, organisms of special inter-
est are outlined below.
Syphilis
Syphilis, an important cause of both stillbirth and neo-
natal death in some regions, will be documented for this
study. Since syphilis is virtually always transmitted trans-
placentally from the mother to the fetus during preg-
nancy and is associated with a maternal antibody
response [16, 17], all cases of syphilis should be identifi-
able by antibodies in maternal blood or alternately, cord
or neonatal blood. For all stillbirths and neonatal deaths,
we will aim to test maternal serum samples for syphilis.
GBS
There are two objectives for GBS in this study. The first
is to determine the prevalence of GBS carriage in the
mothers that will be determined through culture evalu-
ation of a rectovaginal swab collected upon hospital ad-
mission for women admitted with a stillbirth or in
preterm labor, with preterm rupture of membranes or
with a medical condition such as preeclampsia requiring
preterm delivery. Our second related objective is to as-
sess GBS as a cause of stillbirth and neonatal death,
assessed through evaluation of tissue samples collected
at autopsy or by MITS and assessed by PCR.
Acinetobacter
Acinetobacter infection has been described as a cause of
perinatal death, especially in very preterm babies and in
chorioamnionitis associated with preterm birth. Acineto-
bacter has been described as an important contributor
to neonatal infection in several LMIC reports [18–20].
While we suspect that the origin of many fetal or neo-
natal infections is often an intrauterine infection which
led to the preterm birth, Acinetobacter also may be ac-
quired by the infant in the NICU due to contaminated
equipment [18]. The organism will be identified with the
PCR tests. As with GBS, we will evaluate all available
fetal and neonatal tissues and the placentas for Acineto-
bacter in neonatal deaths and stillbirths.
Respiratory syncytial virus (RSV) and other respiratory
viruses
RSV, a known viral pathogen in the neonatal period, and
other respiratory viruses also contribute to neonatal
deaths [21] and potentially stillbirths. To evaluate the as-
sociation of RSV and other respiratory viruses as a cause
for both stillbirth and neonatal death, we will analyze
available samples by PCR for RSV to determine its con-
tribution to mortality.
Cytomegalovirus (CMV)
CMV, a major infectious cause of congenital abnormal-
ities in the fetus and newborn, also causes stillbirths and
neonatal deaths [22]. Most primary maternal CMV in-
fections are clinically silent and undetected. Therefore,
the placenta, blood and fetal/infant tissues will be evalu-
ated for CMV as a cause of death. As with the other in-
fections, using PCR, we will analyze all available samples
for CMV to determine its contribution to mortality.
Ureaplasma and mycoplasma
Ureaplasma and Mycoplasma spp., common commen-
sals found in the vagina, have been associated with pre-
term birth, neonatal infection and stillbirth [22]. These
organisms can cross the amnion and chorion into amni-
otic fluid even with intact membranes. In a study per-
formed by Goldenberg et al. in Alabama, Ureaplasma
and Mycoplasma were frequently cultured from cord
blood of preterm infants displaying a correlation be-
tween gestational age and culture positivity [23]. Both
organisms can be detected by PCR. We will conduct
PCR evaluations on the tissues of all stillbirths and
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neonatal deaths to assess the role of Ureaplasma and
Mycoplasma in preterm mortality and stillbirth.
Maternal colonization and neonatal/fetal infection
In addition to the select pathogens noted above, we will
also test for other organisms known or suspected to
cause stillbirth or neonatal death. Maternal colonization
with pathogens including E. coli, Pseudomonas,
Staphylococcus aureus, and Klebsiella have been associ-
ated with early-onset sepsis in preterm infants and cause
of death in stillbirths. These organisms will be identified
in the cord blood, placenta, and tissues taken at the time
of MITS/autopsy in neonatal deaths and stillbirths by
PCR. Other organisms such as Fusiforme nucleatum, an
oral commensal, and other oral bacteria, such as Cam-
pylobacter spp. are associated with perinatal death, but
have not been routinely investigated as causes of peri-
natal death in LMIC.
Finally, pathogens such as Lyme disease or other path-
ogens are known causes of stillbirth and their import-
ance as a cause of death in South Asia is not clear [9].
Because we will have serum and tissue specimens for
serology and PCR, we will explore whether Lyme disease
and other pathogens are an important cause of stillbirth
and neonatal death in LMIC.
Determining infection as a cause of death
We recognize that presence of an organism by itself does
not indicate that the organism was causal for the stillbirth
or neonatal death. To make a final determination of infec-
tion as cause of death, we will consider the PCR results to-
gether with other clinical signs of infection. Histopathology
results in the placenta and fetus or neonate, white blood
cell counts, and CRP results as well as the presence of or-
ganisms will allow us to designate infection as a cause of
death. The PCR results will help elucidate relatively how
much pathogen DNA was present.
Congenital anomalies
Structural anomalies will be identified through several
methods: ultrasound prior to delivery, visual inspection
at birth, during neonatal care, or at autopsy, and poten-
tially by x-ray evaluation. Photographs of infants and
stillbirths who appear to have a genetic syndrome will be
evaluated by a dysmorphologist. For those with a sus-
pected congenital anomaly disorder, karyotyping for
these deaths will be performed.
Hemoglobinopathies
Routine screening for important hemoglobinopathies in-
cluding sickle cell anemia, other inherited abnormal
hemoglobin such as hemoglobin C and E, and various forms
of decreased hemoglobin production such as the thalassemia
is generally not carried out in the study hospitals.
We will collect a dried blood spot (DBS) card that will
be available for testing of hemoglobinopathies, as needed.
During the study, we will evaluate each infant who dies
with a very low hemoglobin or hematocrit level or with
hydrops for a hemoglobinopathy using hemoglobin
electrophoresis.
Stillbirths will also have a hemoglobin or hematocrit
level performed on cord or heart blood, when feasible.
Those with a low hemoglobin or hematocrit level or evi-
dence of extramedullary hematopoiesis or hydrops will
have a hemoglobin electrophoresis performed.
Metabolic disorders
Virtually all infants born in the US are screened for a
panel of metabolic disorders including hypothyroidism.
These analyses are performed on DBSs collected at birth.
While these conditions are more often related to neuro-
developmental conditions as the infant matures, still-
birth and neonatal death associated with metabolic
disorders have been described. To evaluate these condi-
tions, we will have the DBSs available for analysis for all
liveborn, preterm infants and we will test any infant who
appears likely to have a metabolic disorder.
Specimen collection and storage
Procedures performed to obtain tissue (e.g., liver, lung,
brain) and non-tissue samples (e.g., blood, CSF, and vagi-
nal swabs) from the fetus or neonate, and the mother
will be executed using stringent techniques to minimize
contamination. Storage of all specimens at − 80 °C will
maintain long-term integrity of both microbes and mo-
lecular components (e.g., DNA, RNA, and proteins).
Samples will be kept at study sites.
For tissues acquired through MITS or autopsy following
stillbirth or neonatal death, multiple specimens from the
same organ will be collected and divided for two different
storage conditions: flash-frozen for bacterial growth and/
or molecular testing (i.e. PCR), and formalin-fixed for
histological analysis.
A hierarchy for downstream processing of fetal or neo-
natal blood will be defined. Since blood volumes will be
limited, we will prioritize the allocation of blood for cul-
ture and molecular testing, since the former requires an
adequate volume for reliable results. Additionally, we
will use DBS cards for fetal or neonatal blood collection.
Cause of death determination
The classification systems will use data collected pro-
spectively among women who experience a stillbirth or
deliver a preterm neonatal death. Data will be collected
in a uniform manner across the study sites.
We will define criteria for designating a condition as a
cause of preterm neonatal death or stillbirth (i.e., the cri-
teria to classify a neonatal death as caused by infection,
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asphyxia, IVH, NEC, or RDS, or a stillbirth by condi-
tions such asphyxia with the obstetric or fetal anteced-
ents noted, infection, congenital anomaly). The cause of
death assignments will be consistent with the World
Health Organization (WHO) Internal Classification of
Death (ICD-10) [24]. A panel of experts representing
pediatrics and obstetrics as well as other disciplines such
as pathology, microbiology and radiology, working
within the framework described above, will determine
the cause of death in each of the sites.
Two reviewers will be assigned to review data from each
death and determine the primary and contributory causes.
If the panel members disagree, a third member will review
the case. Reviewers will then discuss any discrepancies in
the classification of primary and contributing causes of
death. The primary cause of death is defined, in accord-
ance with the ICD, as the underlying cause of death or the
disease or injury which initiated the train of morbid events
leading directly to death, or the circumstances of the acci-
dent or violence which produced the fatal injury [24].
Contributing causes of death will be conditions which ad-
versely affected the development of the condition leading
to the death or stillbirth. Contributing causes are an im-
portant consideration as they may be modifiable factors,
amenable to interventions.
Statistical analysis and sample size
We estimate that evaluating 350 preterm neonatal
deaths in each site for a total of 700 preterm neonatal
deaths will provide informative data about preterm
neonatal deaths in each site and be representative of pre-
term mortality in South Asia. Assuming a mortality rate
of 15% among preterm infants, to evaluate 700 deaths,
each site will need to recruit approximately 2500 pre-
term live born infants. In addition, we will enroll the 700
women with stillbirths over the same period.
For the sample size, our main objective is to estimate
the proportion of deaths by cause with a reasonably
sized confidence interval around that proportion. Fig. 1
illustrates the proportion of deaths attributed to any
given cause (i.e., RDS). The vertical axis shows the confi-
dence interval, and the line shows the confluence of the
proportion of deaths and confidence interval (CI) half
width for a given proportion of deaths. For example, if
RDS caused 20% of neonatal deaths and there are 500
neonatal deaths, the Cl width would be about 0.075. If
40% of stillbirths were the result of asphyxia and there
were 500 stillbirths, the width of the CIs would be about
0.09. We chose 350 evaluable neonatal deaths and 350
stillbirths for each site as a reasonable compromise be-
tween higher CIs and study practicality including re-
sources, and timeframe to complete study recruitment.
Discussion
This prospective study on cause of death among still-
births and preterm neonatal deaths will be among the
first to complete in-depth evaluation of deaths in South
Asia, a region which contributes the highest number of
deaths globally. One of the study’s limitations is that to
collect complete data, we are only able to include births
Fig. 1 Confidence Interval (CI) to estimate cause of death given proportion of deaths
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that occur in the study hospitals. However, with the in-
creasing rates of hospital deliveries in Asia, we think the
impact on the study’s generalizability will be minimal.
We will also have less information for infant deaths that
occur during the neonatal period but outside of a study
facility, which will make the performance of an autopsy
and MITS difficult.
However, even with these potential limitations, this
study will more clearly define the role of infectious path-
ogens will be more clearly defined for these settings, in
which most deliveries are now occurring in hospitals.
This study will augment other efforts to define the
contribution of preterm birth and stillbirth to perinatal
mortality. Determining the main risk factors and causes
for perinatal mortality will ultimately inform potential
strategies to reduce the high neonatal mortality and still-
birth rates currently seen in South Asia.
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